Condition

Choroideremia clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Choroideremia clinical trials that are recruiting, in United States. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Choroideremia clinical trials

StudyPhaseWhereStatusRegistered
Assessing vision measurement methods for patients with retinal degeneration — Irvine, California Recruiting Apr 19, 2024
Registry for inherited retinal degenerative diseases — Columbia, Maryland Recruiting May 6, 2015
High-resolution imaging of the retina — Philadelphia, Pennsylvania Recruiting May 31, 2013

All recruiting trials (3)

Related topics

Retinitis PigmentosaStargardt DiseaseAge-Related Macular DegenerationBardet-Biedl SyndromeBatten DiseaseCone Rod DystrophyEye Diseases, HereditaryGeographic AtrophyGeographic Atrophy From Age-related Macular DegenerationLeber Congenital AmaurosisRetinal DiseaseRetinal DystrophiesRod Cone DystrophyStargardt Macular Dystrophy

Quick answers

How many Choroideremia clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.